IE 11 is a very old Browser and it`s not supported on this site

Consolidated statement of comprehensive income for the year ended December 31

in CHF 1 000

 

Notes

 

2022

 

2021

 

 

Operating income

 

 

 

 

 

 

 

 

Interest income

 

 

 

4

 

 

 

Foreign exchange gains

 

 

 

1 253

 

 

 

Other income

 

 

 

4

 

4

 

 

 

 

 

 

1 261

 

4

 

 

 

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

 

 

Net losses from securities

 

4

 

(314 265)

 

(343 595)

 

 

Finance expenses

 

 

 

(1 726)

 

(986)

 

 

Foreign exchange losses

 

 

 

 

(962)

 

 

Administrative expenses

 

8

 

(38 747)

 

(52 595)

 

 

Other expenses

 

9

 

(4 274)

 

(6 607)

 

 

 

 

 

 

(359 012)

 

(404 745)

 

 

Profit/(loss) before tax

 

12

 

(357 751)

 

(404 741)

 

 

 

 

 

 

 

 

 

 

 

Income taxes

 

10

 

(61)

 

(67)

 

 

Profit/(loss) for the period

 

 

 

(357 812)

 

(404 808)

 

 

 

 

 

 

 

 

 

 

 

Total comprehensive profit/(loss) for the period

 

 

 

(357 812)

 

(404 808)

 

 

 

 

 

 

 

 

 

 

 

Income per share in CHF

 

11

 

(6.50)

 

(7.31)

 

 

Diluted income per share in CHF

 

11

 

(6.50)

 

(7.31)

 

 

The notes are an integral part of the consolidated financial statements.

BB Biotech AG uses cookies to improve website usability and ensure the best possible user experience. Use of cookies & disclaimer